ClinicalTrials.gg
RecruitingNCT07586605LyingUpdated Nov 9, 2026

Lying Positions in Intramuscular Injection

An interventional study of Lying before procedure in Ventrogluteal Injections, sponsored by University of Yalova. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University of Yalova · Not applicable, Interventional, and Screening

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Updated Nov 9, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to examine the effects of intramuscular (IM) injections administered in three different lying positions (supine, prone, and lateral) into the ventrogluteal site on patient pain, comfort, and procedural satisfaction. The study will be conducted as a randomized controlled experimental trial with three groups. In Experimental Group 1, patients will be placed in the supine position; in Experimental Group 2, the lateral position; and in Experimental Group 3, the prone position prior to the injection procedure, followed by an IM injection into the ventrogluteal site. Subsequent to the procedure, patients' pain, comfort, and procedural satisfaction levels will be assessed.

02

Conditions studied

  • Ventrogluteal Injections

Keywords

  • intramuscular injection
  • lying position
  • pain
  • patient satisfaction
03

In context

Pressure Ulcer

545 studies on the registry are indexed under Pressure Ulcer; 129 are open to participants now.

This study's planned enrollment of 111 is above the median of 70 across 405 interventional studies indexed under Pressure Ulcer.

Browse Pressure Ulcer studies →

Lead sponsor

University of Yalova is the lead sponsor of 61 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older,
  • Having received an IM injection at least one week prior to the study,
  • Absence of scars, ecchymosis, or hematomas at the injection site,
  • Having a between 18.5 and 24.9 kg/m²,
  • Absence of lower extremity paralysis,
  • Not receiving any oral or parenteral analgesic treatment prior to the injection.

Exclusion criteria

Exclusion Criteria:

  • Failure of the patient to respond to the questions in the post-procedure data collection form.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
111 participants (estimated)

Study arms

  • Experimental
    experimental group 1

    Supine position before intramuscular injection

    Procedure: Lying before procedure

  • Experimental
    experimental group 2

    Lateral position before intramuscular injection

    Procedure: Lying before procedure

  • Experimental
    experimental group 3

    Prone position before intramuscular injection

    Procedure: Lying before procedure

Interventions

  • ProcedureLying before procedure

    Lying position before intramuscular injection

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS) Score for Pain

    patient's pain level (0-10)

    Time frame: during the procedure

Secondary outcomes

  1. Procedural Satisfaction Score

    The Visual Analog Scale (VAS) (0-10) will be employed to measure the degree of patient satisfaction.

    Time frame: during the procedure

  2. Patient Comfort Level

    The Visual Analog Scale (VAS) (0-10) will be employed to measure the degree of patient comfort level

    Time frame: During the procedure

07

Study locations

1 of 1 sites recruiting
  • Yalova University
    Yalova, 77300, Turkey (Türkiye)
    Recruiting
    • Handan Eren, PhD · Contacterennhandan@gmail.com · 05438712771
    • Nurcan Uysal, PhD · Sub investigator
    • Seyda Can, PhD · Sub investigator
    • Ebru Naime Arıkan, MSc · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Nov 9, 2026
Sites
Yalova University is now Recruiting
Nov 9, 2026
Start date
Apr 30, 2026→Jun 30, 2026 (actual)
Nov 9, 2026
Primary completion
Jun 30, 2026→Jan 30, 2027
Nov 9, 2026
Study completion
Aug 30, 2026→Mar 30, 2027
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Not yet recruiting→Recruiting
    Yalova University is now Recruiting
    Start date Apr 30, 2026→Jun 30, 2026 (now actual)
    Primary completion Jun 30, 2026→Jan 30, 2027
    Study completion Aug 30, 2026→Mar 30, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07586605
Lead sponsor
University of Yalova
Responsible party
Handan Eren (Associate Professor, University of Yalova) — Principal investigator
First posted
May 14, 2026
Start date
Jun 30, 2026
Primary completion
Jan 30, 2027 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Handan Eren, PhD
Contact
erennhandan@gmail.com
+905438712771

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion